Europe recommends the approval of Pfizer’s RSV vaccine for older adults and in pregnancy
European regulators on Friday recommended the approval of Pfizer’s RSV vaccine both for older adults and for use in pregnancy.
LONDON — European regulators on Friday recommended the approval of Pfizer’s RSV vaccine both for older adults and for use in pregnancy, which could extend protection against the common respiratory virus to newborns.
The Pfizer vaccine, called Abrysvo, is already approved in the United States for people 60 and older. The Food and Drug Administration is scheduled to weigh in on its use for pregnant people next month.
What's Your Reaction?
